Alaunos Therapeutics, Inc. Operating Lease, Liability, Noncurrent
Alaunos Therapeutics, Inc. (TCRT) had Operating Lease, Liability, Noncurrent of $4.71 million as of 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2021-11-08
- 2021-09-30: Operating Lease, Liability, Noncurrent $4.71M.
- 2021-06-30: Operating Lease, Liability, Noncurrent $4.89M.
- 2021-03-31: Operating Lease, Liability, Noncurrent $3.87M.
- 2020-12-31: Operating Lease, Liability, Noncurrent $4.00M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2021-09-30 | $4.71M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $4.89M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $3.87M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.00M 10-Q · filed 2021-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |